Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease
Benedikt Simbrunner(Austrian Academy of Sciences), Diana Julie Leeming(Nordic Bioscience (Denmark)), Ida Falk Villesen(University of Southern Denmark), Bernhard Scheiner(Medical University of Vienna), M.A. Karsdal(Nordic Bioscience (Denmark)), Joana Calvão(University of Coimbra), Georg Semmler(University of Southern Denmark), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Rodrig Marculescu(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), Jurij Maurer(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Kerstin Zinober(Medical University of Vienna), Lukas Hartl(Medical University of Vienna)
Cited by 9
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561